Tip: Need to know the basics about Appendix Cancer? Click here.
Wake Forest Finds Oxaliplatin Dosage for Peritoneal Cancer
Researchers from Wake Forest University have completed a Phase I study that may help improve the survival rate for patients with appendix cancer or colorectal cancer that’s spread to their abdomen. Wake Forest’s study identified the maximum amount of a chemotherapy drug peritoneal cancer patients can successfully tolerate during Intraperitoneal Hyperthermic Chemotherapy (IPHC) treatments following [...]
click here to read full article...